Key result
High serum vitamin D linked to ~55% lower fatal cancer risk in coronary angiography patients.
Why the study?
Epidemiologic studies on vitamin D's protective role against cancer are inconclusive, and prospective data on serum 25-hydroxyvitamin D levels and total cancer mortality are scarce.
Does higher serum 25-hydroxyvitamin D reduce the risk of fatal cancer in patients referred to coronary angiography?
Cohort (n=3,299)
Does higher serum 25-hydroxyvitamin D reduce the risk of fatal cancer in patients referred to coronary angiography?
Answers are grounded in this paper and cite their sources.
Higher serum levels of 25-hydroxyvitamin D are associated with a significantly reduced risk of fatal cancer in patients referred for coronary angiography.
Accumulating evidence suggests that vitamin D may protect against cancer, but results from epidemiologic studies are inconclusive so far, and other studies looking into the prospective association of total cancer mortality and serum 25-hydroxyvitamin D [25(OH)D] levels, which are considered to be the best indicator of vitamin D status, are scarce. We measured 25(OH)D and 1,25-dihydroxyvitamin D in 3,299 patients from the Ludwigshafen Risk and Cardiovascular Health study. The baseline examination was done between July 1997 and January 2000 and included a fasting blood sampling in the morning before coronary angiography. During a median follow-up period of 7.75 years, 95 patients died due to cancer. After adjustment for possible confounders, the Cox proportional hazard ratio (95% confidence interval) of the fourth 25(OH)D quartile was 0.45 (0.22-0.93) when compared with the first quartile and the hazard ratio per increase of 25 nmol/L in serum 25(OH)D concentrations was 0.66 (0.49-0.89). We found no association between serum 1,25-dihydroxyvitamin D levels and fatal cancer. In summary, our data suggest that low levels of 25(OH)D are associated with increased risk of fatal cancer in patients referred to coronary angiography and that the maintenance of a sufficient vitamin D status might therefore be a promising approach for the prevention and/or treatment of cancer.
No takes yet. Share an insight, caveat, or question.
Pilz et al. (2008) conducted a cohort in patients referred to coronary angiography (n=3,299). Serum 25-hydroxyvitamin D [25(OH)D] levels vs. First quartile of 25(OH)D was evaluated on fatal cancer (HR 0.45, 95% CI 0.22-0.93). High serum 25-hydroxyvitamin D levels (fourth vs first quartile) were associated with a lower risk of fatal cancer in patients referred to coronary angiography.
Synapse has enriched 10 related papers. Consider them for comparative context: